Skip to main content
Meeting Highlights
Lung Cancer, ASCO Highlights
Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC
Phoebe Starr
Phoebe Starr
Read More
Meeting Highlights
Prostate Cancer, ASCO Highlights
¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
Phoebe Starr
Phoebe Starr
Read More
Meeting Highlights
ASH Highlights, Leukemia, Novel Pharmaceuticals
Oral Vodobatinib Elicits Durable Responses in Heavily Pretreated Patients with Chronic Myeloid Leukemia
Read More
Meeting Highlights
ASH Highlights, Myelofibrosis, Novel Pharmaceuticals
Momelotinib, a Novel JAK Inhibitor, Makes Inroads in Intermediate- or High-Risk Myelofibrosis
Read More
Meeting Highlights
ASH Highlights, CAR T-Cell Therapy, Lymphoma
ZUMA-12: Axicabtagene Ciloleucel Shows Substantial Benefit in High-Risk Large B-Cell Lymphoma
Read More
Meeting Highlights
ASH Highlights, Clinical Trials, Lymphoma
Step-Up Glofitamab Dosing Induces High Response Rates in Relapsed or Refractory Non-Hodgkin Lymphoma
Read More
Meeting Highlights
ASH Highlights, Graft-versus-Host-Disease
Ruxolitinib in Graft-versus-Host Disease: Practice-Changing Results
Read More
Meeting Highlights
ASH Highlights, Myelodysplastic Syndromes
Pevonedistat plus Azacitidine Improves Outcomes versus Azacitidine Monotherapy in High-Risk MDS
Read More
Meeting Highlights
ASH Highlights
A Phase 2 Study of Isatuximab for Patients with Previously Treated AL Amyloidosis
Read More
Meeting Highlights
ASH Highlights
VRD Consolidation Followed by Lenalidomide Maintenance versus Maintenance Alone in Transplant-Eligible Patients with NDMM
Read More
Page 4 of 17
Results 31 - 40 of 169